These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6624807)

  • 1. Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy.
    Clarke-Pearson DL; Synan IS; Creasman WT
    Am J Obstet Gynecol; 1983 Oct; 147(4):369-75. PubMed ID: 6624807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of anticoagulant therapy in venous thrombo--embolism.
    O'Sullivan EF
    Med J Aust; 1972 Nov; 2(20):1104-7. PubMed ID: 4640564
    [No Abstract]   [Full Text] [Related]  

  • 3. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimal duration of anticoagulant treatment of venous thromboembolism].
    Couturaud F; Grand'Maison A; Kearon C
    Presse Med; 2000 Jul 8-15; 29(24):1379-85. PubMed ID: 10938698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Internal medicine therapy of venous thromboembolism].
    Tsakiris DA; Marbet GA
    Ther Umsch; 1992 Dec; 49(12):833-6. PubMed ID: 1485281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of venous thromboembolism.
    Ginsberg JS
    N Engl J Med; 1996 Dec; 335(24):1816-28. PubMed ID: 8943165
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
    ; Büller HR; Gent M; Gallus AS; Ginsberg J; Prins MH; Baildon R
    N Engl J Med; 1997 Sep; 337(10):657-62. PubMed ID: 9280815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy.
    Chan A; Woodruff RK
    Aust N Z J Med; 1992 Apr; 22(2):119-22. PubMed ID: 1530532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.
    Hutten BA; Prins MH; Gent M; Ginsberg J; Tijssen JG; Büller HR
    J Clin Oncol; 2000 Sep; 18(17):3078-83. PubMed ID: 10963635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant therapy in right-sided thromboembolic disease.
    Robin ED; Burke CM
    Chest; 1986 Jun; 89(6):882-4. PubMed ID: 3519111
    [No Abstract]   [Full Text] [Related]  

  • 12. Venous thromboembolism and gynecologic surgery.
    Bonnar J
    Clin Obstet Gynecol; 1985 Jun; 28(2):432-46. PubMed ID: 2410173
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia.
    Lapecorella M; Lucchesi A; Di Ianni M; Napolitano M; Coletti G; Di Leonardo G; Dell'Orso L; Barnabei R; Mariani G
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):85-90. PubMed ID: 19923984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage.
    Petitti DB; Strom BL; Melmon KL
    Am J Med; 1986 Aug; 81(2):255-9. PubMed ID: 3740082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.